review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1139/Y05-159 |
P698 | PubMed publication ID | 16845892 |
P2093 | author name string | Stewart C Whitman | |
Tanya A Ramsamy | |||
P2860 | cites work | Atherosclerosis — An Inflammatory Disease | Q26776972 |
Cutting edge: the mouse NK cell-associated antigen recognized by DX5 monoclonal antibody is CD49b (alpha 2 integrin, very late antigen-2) | Q28207906 | ||
Autoreactivity by design: innate B and T lymphocytes | Q28208367 | ||
CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides | Q28254991 | ||
A major role for VCAM-1, but not ICAM-1, in early atherosclerosis | Q28365883 | ||
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells | Q28509783 | ||
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice | Q28591350 | ||
CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4 | Q28594577 | ||
Biology of natural killer cells | Q29619728 | ||
Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E | Q33962949 | ||
NKT cells: facts, functions and fallacies. | Q34091324 | ||
Natural killer cells, viruses and cancer | Q34119645 | ||
Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice | Q34142722 | ||
Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits | Q34276329 | ||
The vascular-associated lymphoid tissue: a new site of local immunity | Q34372310 | ||
Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice | Q43989979 | ||
Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor-deficient Mice by altering lymphocyte and macrophage phenotypes | Q44011973 | ||
IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice | Q44090158 | ||
B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice | Q44212443 | ||
Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse | Q44342113 | ||
Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice | Q44779169 | ||
Proatherogenic role for NK cells revealed | Q44922350 | ||
Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice | Q46141600 | ||
Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions | Q46711267 | ||
NK cell receptors | Q46858751 | ||
Natural killer T cells accelerate atherogenesis in mice | Q47685326 | ||
Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. | Q52194636 | ||
Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. | Q55060871 | ||
Protective Role of Interleukin-10 in Atherosclerosis | Q58150380 | ||
Phenotypic properties, interleukin 2 production, and developmental origin of a "mature" subpopulation of Lyt-2- L3T4- mouse thymocytes | Q34372941 | ||
Immune mechanisms in atherosclerosis | Q34462668 | ||
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis | Q34620005 | ||
Immunotherapy with ligands of natural killer T cells | Q34688305 | ||
Innate and adaptive immunity in the pathogenesis of atherosclerosis | Q34794757 | ||
The regulatory role of Valpha14 NKT cells in innate and acquired immune response. | Q35051569 | ||
In vivo natural killer cell activities revealed by natural killer cell-deficient mice | Q35080152 | ||
Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity | Q35092539 | ||
Composition and classification of human atherosclerotic lesions | Q35433689 | ||
The dynamic life of natural killer cells | Q35698475 | ||
CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells | Q35787847 | ||
The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice | Q35792034 | ||
The immunoregulatory role of CD1d-restricted natural killer T cells in disease. | Q35811028 | ||
Lymphocytes are important in early atherosclerosis | Q36072647 | ||
Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis. | Q36072740 | ||
Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells | Q36096376 | ||
T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse | Q36142970 | ||
CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice | Q36365696 | ||
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis | Q36367900 | ||
Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers | Q36368804 | ||
The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families | Q36369224 | ||
Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein | Q36371349 | ||
CD1d-dependent activation of NKT cells aggravates atherosclerosis. | Q36399122 | ||
In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers | Q36404648 | ||
Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells | Q37011453 | ||
alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria | Q37229005 | ||
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice | Q37372718 | ||
The involvement of lipoproteins in atherogenesis. Evolving concepts | Q38000908 | ||
The beige mutation in the mouse selectively impairs natural killer cell function | Q40713185 | ||
Natural killer cell proliferation induced by anti-NK1.1 and IL-2. | Q41036019 | ||
The PDAY Study: natural history, risk factors, and pathobiology. Pathobiological Determinants of Atherosclerosis in Youth | Q41500653 | ||
Developmentally regulated expression of T cell receptor beta chain variable domains in immature thymocytes | Q42049694 | ||
Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma | Q42162162 | ||
Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice | Q42757050 | ||
Dietary supplementation with methionine and homocysteine promotes early atherosclerosis but not plaque rupture in ApoE-deficient mice | Q43738082 | ||
A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells | Q43756252 | ||
P433 | issue | 1 | |
P921 | main subject | lessons learned | Q1673259 |
P304 | page(s) | 67-75 | |
P577 | publication date | 2006-01-01 | |
P1433 | published in | Canadian Journal of Physiology and Pharmacology | Q5030248 |
P1476 | title | Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies | |
P478 | volume | 84 |
Q37609178 | Altered expression of Raet1e, a major histocompatibility complex class 1-like molecule, underlies the atherosclerosis modifier locus Ath11 10b. |
Q40041296 | Cholesterol-independent effects of atorvastatin prevent cardiovascular morbidity and mortality in a mouse model of atherosclerotic plaque rupture |
Q37808645 | Current advances in understanding of immunopathology of atherosclerosis |
Q42628303 | Immune activation resulting from NKG2D/ligand interaction promotes atherosclerosis |
Q37325024 | Immune and inflammatory mechanisms of atherosclerosis (*) |
Q57132246 | Immunological aspects of atherosclerosis: Figure 1 |
Q88221891 | MICA/B expression in macrophage foam cells infiltrating atherosclerotic plaques |
Q58820736 | Strain-dependent susceptibility for hypertension in mice resides in the natural killer gene complex |
Q38115117 | The CD1d-natural killer T cell axis in atherosclerosis. |
Search more.